“First In-Person Summit after Two Years”, JUNE 22-23, 2022 at the Crowne Plaza Suites, Foster City, CA

Theme: “Driving Transformation of Life Sciences in the Post-Pandemic World”.

A Glimpse into the Summit!

Driving Accelerated Clinical Trials, Reinforcement of the Transportation Network and Digital Integration of the Healthcare industry have been the strategic outcomes of the two-year war on the COVID Pandemic. The 2022 Summit of BSMA will deliver innovations and road maps to meet these challenges to transform healthcare as we know it. You do not want to miss three conferences in one!

On Day 1, June 22, JOIN US as the morning will begin with the CLINICAL SUPPLY WORKSHOP.  The focus is on avoiding clinical supply chain mistakes.  Following the workshop, the main conference opens with a scrumptious lunch at noon followed by the PLENARY SESSION.  At 6pm, be prepared to have a lot of fun at our very first SOCIAL NETWORKING PARTY!  There will be delicious food, wine and beer tasting, live music, and most important – NETWORKING!

On Day 2, three full day panel tracks to address the problems and solutions of Clinical Trials, Transportation, and Digital Transportation.  Scroll down for more information.

Ready for a Weekend Vacation?  Or, even just a great Weekend?

Discover the San Francisco Bay Area before and/or after attending BSMA’s 2-day Summit!

Bring your family and experience Golden Gate Bridge, cable cars, a sparkling bay, and streets lined with elegant Victorian homes, amongst other iconic treasures.  The Bay Area is also home to some of the world’s finest wine country-Napa Valley, Sonoma, and Livermore, just to mention a few.  Not to forget waterfront towns, dramatic beaches, and a diverse number of renown restaurants to meet your tastebud’s expectations.

And, see what else can be your pleasure by extending your visit here….Click here

PINSTRIPES

36 Hillsdale Mall
San Mateo, CA
94403
650-781-4720

CROWNE PLAZA SUITES

1221 Chess Drive, San Mateo, CA, CA 94404, US    (650) 431-2517

RESERVATIONS:  Discount rates for Attendees.  Rooms are limited so please make your reservations as soon as possible.  Click Here for Reservations.

DIRECTIONS

12th BSMA Conference 2019
BSMA Awards 2019
BSMA Networking 2019

“Driving Transformation of Life Sciences in the Post-Pandemic World”

SUMMARY OF THE FULL TWO (2) DAYS

DAY 1

7:30 am – On-going: REGISTRATION for workshop
7:30 – 8:30 am: MEET & GREET BREAKFAST
8:30 am – 12:00 pm CLINICAL SUPPLY WORKSHOP
11:00 am – 12:30 pm On-going REGISTRATION for Summit
12:30 pm -2:00 pm NETWORKING LUNCH & Welcome Address
2:00 pm – 5:00 pm PLENARY SESSION
6:00 pm – 10:00 pm SOCIAL NETWORKING PARTY at PINSTRIPES, San Mateo, CA

DAY 2

7:30 am – 8:30 am – On-going REGISTRATION
7:30 am – 8:30 am – MEET & GREET NETWORKING BREAKFAST
8:30 am – 4:30 pm – 3 Track Sessions:  Clinical Supply Chain, Transportation & Logistics, & Digital Transformation
4:30 pm – 6:30 pm COCKTAIL RECEPTION & AWARDS CEREMONY

NOTE:  Event program is still in progress.

DAY

ONE

8:30 am – 12:00 pm  Clinical Supply Chain Workshop

Syracuse Room

AVOIDING CLINICAL SUPPLY CHAIN MISTAKES YOU ARE ABOUT TO MAKE

REGISTRATION & MEET/GREET BREAKFAST

Join Luke Moyer, Head of Global Clinical Supply Chain at Incyte, as he leads a fun and interactive workshop targeted to BSMA attendees who are new to the Clinical Supply Chain Role, as well as experienced clinical supply chain professionals seeking to learn and share best practices.  Working in clinical supply chain can be intimidating to say the least.    It’s an urgent and stressful job with many moving pieces and very few clear answers.  Since Luke’s first clinical supply chain job 25 years ago, he’s learned a lot about what works and what doesn’t, and continues to remind us that “every day you work in clinical supplies is a school day.”  This workshop is designed to accelerate the learning process for novice supply chain managers, and help sharpen the skills of those with experience, helping them to understand key fundamentals and avoid some of the pitfalls many of us learned the “hard way.”

Topics include:
  • Your forecast is wrong, and that’s okay
  • Building a simple but powerful forecast in Excel
  • The difference between overage and safety stock
  • Stability protocols and supply planning
  • Preventing waste and rework using pull vs. push
  • IRT set-up basics

Luke Moyer, Head, Global Clinical Supply Chain, Incyte

11:00 am – 5:30 pm BSMA CONFERENCE

12:30 – 2:00 PM PLENARY NETWORK LUNCHEON

Balboa & Columbus Ballrooms

1:30 pm – 1:40 pm Welcome Address:  SUPPLY CHAIN EXECUTION SAVES HUMAN LIVES – THE UNIVERSAL OUTCOME OF THE PANDEMIC 

Devendra Mishra, Executive Director, BSMA

1:40 pm – 2:00 pm  “THE 2021 LIFE SCIENCES SECTOR REPORT OF CALIFORNIA”

The report of California’s life sciences sector, which directly employed 313,230 people, attracted $12.5 billion in venture capital (VC) and received $5.0 billion in funding from the NIH, will be highlighted to demonstrate its resilience and show the path forward for the ecosystem.

Mike Guerra, President & CEO, California Life Sciences (CLS)

2:00 pm – 5:00 pm PLENARY SESSION

Balboa & Columbus Ballrooms

2:00 – 2:30 pm  KEYNOTE ADDRESS: SUPPLY CHAIN OF COVID-19 VACCINES: TRIALS, TRIBULATIONS & SAVING LIVES!

Supply chain has become a household word in the COVID-19 pandemic where it is the universal perspective for all problems diagnosed and solved. During this period, C-Suites of all companies have been forced to make a rigorous assessment of their supply chain, only to discover its vulnerability and how inadequate it was to save human lives. A CEO will tell the story of how the broken links were identified, reactive steps taken to fix the problem, a holistic view of the ecosystem replaced the siloed one, a strategic plan was developed to achieve resilience and agility, and how change management was launched to transform the way of doing business and serving their patients. The adoption of an end-to-end, holistic supply chain management philosophy has led to a cultural change for the enterprise.

Dr. Prashant YadavThink-tank Fellow, Professor, & Researcher. CGDEV, INSEAD and Harvard Med. Supply Chains for Medical Products   

2:30 – 3:00 pm  DISRUPTION & SUSTAINABILITY FOR LIFE SCIENCE TRANSFORMATION USING METRICS & SIX SIGMA (LITE) METHODOLOGY

The Life science industry is past the debate of managing disruptions while aligning to a sustainability agenda. Building resilience and corporate responsibility into organizational DNA is a necessary requirement. While such a transformation can be daunting, steps can be executed focusing on quick wins while aligning to an overall strategy. Such steps involve focusing on leading indicators – metrics which influence lagging indicators. These indicators include lead-time, on time in full and supplier diversity. This will be a collaborative session where a Six-Sigma methodology and a metricized approach will be reviewed and improved upon by attendees.

Sudy Bharadwaj, Vice President, Strategic Engagements, SAP

3:00 – 3:30 pm  TRANSFORMING THE TRANSPORTATION NETWORK TO A CONTINOUS PROCESS: MEETING THE DRACONIAN CHALLENGE!

How can drug manufacturers incorporate technologies, in conjunction with forwarders and carriers, to design or select proper packaging and transportation methods to mitigate adverse environmental impacts? How can forwarders/carriers design their SOPs to ensure compliance with Good Distribution Practices? The solution will cover the transportation process of every shipment at every step, considering truck transport, facility storage, limiting tarmac exposure, and timely delivery. The objective is to ensure that every shipment complies with its lane-based transportation SOPs, which validates routes, timing, and product stability limits based on exposure to environmental effects. This can be achieved economically at scale, minimizing product loss, reduced CAPA/SCARs, accurate measurement of forwarder/carrier performance, and a resilient and dependable supply chain. This is like Good Manufacturing Practices, the standard practice for consumer products.

Rich Kilmer, President & CEO, CargoSense

 

3:30 – 4:00 pm  NETWORK BREAK

4:00 – 4:30 pm  HOW To ENSURE THAT CLINICAL SUPPLIES IS A TRUE ENABLER OF FASTER CLINICAL DEVELOPMENT TIMELINES

  • With pharma and biotechs’ ambitions to do more with less, the supply chain easily becomes the center of attention in the attempt to supply trials faster, more efficiently, avoiding any stockout and with lower waste
  • Learn how cross-departmental decision-making in the clinical trial supply, protocol design, upstream manufacturing saves time, drug, costs and ensures all patients are treated at all times;
  • Through case studies, we will illustrate the reasons why the supply chain is one of the key enablers of faster time to market, with a 2-6 months acceleration in a program.

Cyrille Lefevre, Life Science Sr. Expert, N-Side

4:30 – 5:00 pm A GUIDE FOR US BIOTECH LAUNCH IN EUROPE: TRIALS, TRIBULATIONS & TRIUMPHS!

The session will consist of comprehensive Introductory Insights from an expert to address the challenges, pitfalls and personal experiences, followed by a Panel Discussion. Guidelines will be provided for project organization and cross-functional support requirements to manage the EU launch complexity. Useful suggestions will be shared for the selection of EU service providers (3PL, Warehousing & Transportation) and implementation challenges. The Panel Discussion will focus on the pros & cons of engaging in a EU launch readiness project and building your own EU infrastructure. The importance of the cross-functional collaboration to tackle detailed functional interdependencies will be examined. The wrap up will include the testimony on experience related to EU launch readiness, do and do not do and professional feedback.

PANELISTS:
Alyson Naughton, Head of Supply Chain, ADC Therapeutics
Gaspard Jouandon, Former Director of Supply Chain, Novimmune
Franck Toussaint, Managing Director, Biolog Europe
Linda Bliss, Director, Supply Chain Planning, Adaptive Biotechnologies and former Director, Global Launch Management at Merck KGaA Darmstadt, Germany
MODERATOR: Laurent Foetisch, Managing Director, Supply Chain Operations SA

5:00 – 5:30 pm THE NEW WORKPLACE RENAISSANCE

In the last two years, the Pandemic has produced a Tectonic shift in the employer, employee, work and family relationship where virtual communication technologies and organizational/personal adaptability came to the rescue. The outcome was greater productivity and creativity achieved while the mental and social dimensions suffered traumatic impact, much of it remaining to be understood. The research will analyze the current situation and how it is likely to evolve in the future.

Speaker: TBD

5:45 pm PROCEED TO NETWORKING CELEBRATION AT PINSTRIPES AT 6:00 PM

6:00 pm – 10:00 pm SOCIAL NETWORKING PARTY

Fun time while networking: food,  wine and beer tasting, games, bocce, bowling, live music

DAY

TWO

TRACK 1

CLINICAL  

Chairman:

Bill Coakley

EVP of Clinical & Commercial SC Mgmt

TRACK 2

TRANSPOR-TATION 

Chairman: 

Jeff Tucker

CEO, Tucker Company Worldwide

TRACK 3

   DIGITAL  

Chairman:  

Randy Bradley

EVP Digital Transforma-tion in Life Sciences

7:30 am – On-going REGISTRATION

7:30 – 8:30 am MEET AND GREET BREAKFAST

8:30 am – 4:30 pm TRACK 1: SCM INNOVATIONS FROM CLINICAL TRIALS TO COMMERCIALIZATION

Balboa Ballroom

Chairman:  Bill Coakley, Executive Vice President of Clinical & Commercial Supply Chain Mgmt

8:30 – 9:15 am  TOOLS & TECHNOLOGIES BEYOND EXCEL: A SYSTEM EVOLUTION FOR ERP READINESS

Tools & technologies for supporting the planning, manufacturing, storage and distribution of drug product and materials often lag behind in its ability to support successful commercial launches. Many Life Science companies rely on Excel, information from service providers and non-integrated solutions for making critical supply chain decisions. What is the journey companies should make to advance their capabilities from Excel to a full-blown ERP solution? When should these changes occur? How can they obtain the necessary support?

PANELISTS:
Rutesh Desai, Senior Manager, Supply Chain Systems, Beigene
Luke Moyer, Head, Global Clinical Supply Chain, Incyte
Aparna Seksaria, Product Manager, SAP Life Science Project Management, SAP
Yogendra Chordia, Co-Founder, Schrocken
Moderator: Bob Lamont, Partner, Clarkston Consulting

9:15 – 9:45 am  CLINICAL SUPPLIES PLANNING: STOCHASTIC AND DETERMINISTIC APPROACHES

Tools and approaches vary for clinical supply planning and each has its benefits.  Hear industry leaders share their experiences and perspectives on the value, pros and cons for each option.

PANELISTS
David Volk, Sr. Director, Clinical Supply Operations, Genentech
Jan Pieter Kappelle, VP Strategy, 4G Clinical
Cyrille Lefevre, Life Science Sr. Expert, N-Side
Marc Trombella, Associate Director, Supply Chain, BioMarin Pharmaceuticals
Moderator: Dan Silva, Partner, Tenthpin

9:45 – 10:15 am ENSURING DRUG ACCOUNTABILITY & RECONCILIATION: A CRITICALLY REWARDING MISSION!

Drug accountability and reconciliation requires tracking and maintaining significant amounts of information across your supply chain network and can be one of the major pain points and obstacles for achieving FDA approval for your drug.  Panelists will share best practices, watchouts, & experiences around the requirements and sources of information when going through this process as well as provide some take home guidance on items to consider.

PANELISTS
Derek Thornton, Sr. Manager, Clinical Systems, Amgen
Brittney Elko, Sr. Director, Supply Chain, Tricida
Kathleen Williams, CT PA Manager, Almac Clinical Technologies
Moderator: Jon Paras, Vice President Strategic Solutions, YPrime

10:15 – 11:00 am  NETWORK BREAK

11:00 – 11:45 am  HOW TO SUCCESSFULLY IMPLEMENT DIRECT-TO-PATIENTS CLINICAL STUDIES

Direct to Patient, Site to Patient & Lessons learned from first hand experience over the past few years including protocol, regulatory and technology considerations.  Including setting realistic expectations and ensuring the best possible patient experience.

Jan Pieter Kappelle, VP Strategy, 4G Clinical
Nicole Gray, Director, Strategic Supply Solutions, Catalent

11:45 am – 12:30 pm  TRANSITIONING FROM CLINICAL TO COMMERCIAL: ENSURING SUCCESSFUL PRODUCT LAUNCH

The transfer of R&D know how and governmental compliance requirements to commercial operations is a monumental chasm that must be overcome in terms of people, processes, organization structures and technology, in addition to understanding the inherent cultural differences of science and mass production. Exacerbating the challenge is the complexity of the ecosystem comprising of the drug developer, CRO, CMO, Logistics and FDA. The diverse stakeholders will address the challenges of bringing drug discovery to the market for significantly greater efficacy, higher success rate, shorter lead time and lower cost. Considering that there is a superordinate goal of maximizing healthcare, exponentially higher alignment of businesses is practical.

PANELISTS
Karl Lovett, Senior Director, Global Supply Chain, Beigene
Arvind Singh, Executive Director, Supply Chain, SK Pharmateco
Ann McMahon, General Manager, Commercial & Integrated Development Operations, Catalent
Marc Trombella, Associate Director, Supply Chain Planning, BioMarin Pharmaceuticals
Chris Armstrong, President Clinical Trials, Thermo Fisher Scientific
Moderator: Bill Coakley, Executive Vice President, Supply Chain, BSMA

12:30 – 2:00 pm  NETWORK LUNCHEON

2:00 – 2:45 pm  LESSONS LEARNED IN THE PLANNING AND EXECUTION OF CLINICAL STUDIES 

Clinical supply professionals and service providers will address challenges and solutions around forecasting, IRT, distribution, comparators and resupply.

PANELISTS
Ryan Mills – Director, Supply Chain, Denali Therapeutics
Scott Sabalvaro – Sr Manager, Clinical Supply Chain, Amgen
Dan Hanson, Global Head of Client Services, Clinical Trial Division, Thermo Fisher Scientific
Malou Berdan – Associate Director, Clinical Supply Chain & Logistics, Beigene
Moderator: Mike Dallmann – Senior Director Supply Chain, Avidity Biosciences

2:45 – 3:15 pm  A NOVEL APPROACH TO IRT VENDOR OVERSIGHT

Ensuring clinical trial inspection readiness is not an easy task for sponsors. The coordination of multiple vendors, systems, and other contributors to a clinical trial execution makes the task more complex and time-consuming. YPrime will facilitate a discussion on concepts and novel ideas related to the vendor oversight process for sponsors.

Facilitator: Jon Paras, Vice President Strategic Solutions, YPrime

3:15 – 4:00 pm  NETWORK BREAK

4:00 – 4:30 pm  TECHNOLOGY SHOWCASE

4:30 – 4:50 pm  AWARDS CEREMONY

4:45 – 6:00 pm  COCKTAIL RECEPTION

WRAP UP

  8:30 am – 4:30 pm

HOW DO YOU NAVIGATE THROUGH THE PERFECT STORM FACED BY TRANSPORTATION & LOGISTICS IN HEALTHCARE?

Chairman:  Jeff Tucker, CEO, Tucker Company Worldwide

8:30 – 8:45 am WELCOME ADDRESS: Jeff Tucker, CEO, Tucker Company Worldwide

8:45 – 9:30 am SUPPLY CHAIN RESILIENCY IS AS IMPORTANT TO COMPANIES AS IT IS TO NATIONAL SECURITY 

Noted expert in catastrophe planning and the building of resilient supply chains, Phillip Palin, advises the highest levels of the federal government, from emergency officials to national security and the White House. Mr. Palin will review critical learning from the earliest days of Covid-19, including some near catastrophes in healthcare supply chains, and what life-science companies need to think about today, considering the frequency of black swan events such as Covid, port congestion, strikes, wars, tariffs and more. Normal is managing chaos. Resiliency has become essential to staying in business.  

Philip J. Palin, Principal, Private Practice, Supply Chain Resilience, Catastrophe Preparedness 

9:30 – 9:55 am  INDUSTRY PLATFORM TO MANAGE DATA ACROSS AIR, SEA & TRUCK FREIGHT

Presentation of SkyCell SECURE will be made which is an interoperable Supply Chain Operating System to manage simulation data with real time data and info across all shipping modalities, for any pharma company, manufacturer’s container/packaging/monitoring and global freight forwarder. SECURE brings all shipments data under one platform to Track & Trace, accelerate product release, automatically detect counterfeit and theft of goods, and significantly increase workflow efficiency. In addition to predicting the risk of delivering sensitive drugs by air, it can also reduce CO2 emissions by almost half.

Axel Hartman, Business Development Director, SkyCell Corporate

9:55 – 10:40 am GLOBAL TRACKING AND TEMPERATURE MONITORING IN TRANSPORTATION TODAY 

The Covid vaccine distribution–and the ultra-low temperatures some had to maintain–accelerated the development and adoption of various IOT devices to both track the location and monitor the temperature of product. Hear from experts in both the service provider side and the pharmaceutical manufacturing side where this technology is today, and where it’s going.

Dina Bunn, Vice President, Customer Experience, Pharma & Healthcare, JAS Worldwide
Kunal H. Punjabi, Regional Sector Head, Life Sciences & Chemicals, DHL Global Forwarding  

10:40 – 11:00 am NETWORK BREAK

11:00 – 11:45 am SUCCESSFULLY NAVIGATING THE LONGEST AND HIGHEST DEMAND FOR TRUCKING IN HISTORY 

For nearly two years since Spring 2020, demand for trucking has set new historical records. The strain of the post-Covid increase in consumer spending combined with unprecedented shifts in supply chains, with entire industries such as hospitality and restaurant chains temporarily upended, continue to present profound problems for shippers trying to obtain regular, reliable freight transportation. Ports and rail terminals are backed up. Air freight is at record demand. All segments require trucking. Truck drivers are entering business for themselves in record numbers too, skewing the number of drivers toward the smaller size carrier. Hear from industry experts how to secure reliable capacity in cold chain trucking.  

Jeff Tucker, CEO, Tucker Company Worldwide 
Andrew Boyle, Co-President, Boyle Transportation

11:45 am – 12:00 pm SERVICE SHOWCASE – UNITED CARGO

The Post-Covid Airfreight Market – Airliner’s View

Manu Jacobs, Managing Director Specialty Products, United Cargo – United Airlines

12:00 – 12:45 pm ENVIRONMENTAL SUSTAINABILITY IN GLOBAL TRANSPORATION 

According to research at MIT, including ports and warehouses, global freight transportation accounts for 11% of all greenhouse gas emissions. And while sustainability may have taken a back seat to supply chain chaos since mid 2020, many companies in both manufacturing and in transportation are taking deliberate and important steps along the pathway to neutral carbon in a few short years. Hear from these companies on what they’re doing, and how each of us might learn, or join in the movement.  

Kunal H. Punjabi, Regional Sector Head, Life Sciences & Chemicals, DHL Global Forwarding
Jennifer L. Haigh, Head of Specialty Products – Americas, United Cargo
Bob Gahan, V.P. & Head of Healthcare,  Kuehne + Nagel North America

12:45 – 2:00 pm NETWORK LUNCHEON

2:00 – 2:25 pm ECONOMICAL DELIVERY OF COLD CHAIN PRODUCTS FOR DIRECT RELIEF: TEMPERATURE PROFILE OF GLOBAL SHIPPING LANES, THERMAL FOOTPRINT OF PAYLOADS & SIMULATION

Direct Relief, in the mode of shipping into disaster areas with infrequent transportation lanes, faces unexpected challenges throughout the world. A three-fold approach of a virtual cold chain to resolve these issues begins with generation of characteristic temperature profiles of a shipping lane worldwide, based on accurate temperature data from thousands of global weather stations. This leads to the determination of the thermal footprint of a passive insulated and temperature-sensitive payload. Finally, simulation yields a lane-independent performance benchmark to compare different pack outs, configurations, and systems on the market for optimization. A case study of distribution lifesaving products into Rwanda and Mali with limited lane data will be presented.

Stefan Braun, CEO, SmartCAE
Mike Wooten, Cold Chain Manager, Direct Relief

2:30 – 3:15 pm GLOBAL TRANSPORTATION ECONOMIC REVIEW – INCLUDING AIR, OCEAN, TRUCK AND RAIL 

This session will include a comprehensive economic review and update of each mode of transportation. We will detail the state of each mode, and what analysts see as the point at which each may enter a state of relative equilibrium (and if they see that point). If you are involved in any aspect of supply chain and logistics, you will need to hear this. Procurement and logistics managers looking for insights to provide to the C-level and others, this is your session.  

Lee Klaskow, Sector Head and Senior Analyst, Bloomberg

3:15 – 3:30 pm NETWORK BREAK

3:30 – 4:15 pm OH, THE PLACES YOU’LL GO…YOU’LL NEED TEMP CONTROL! TEMP CONROL SHIPPING DEEP DIVE 

The session we’ll go deep and wide into discussion around technology and methods of shipping that keep your product safe and effective throughout its entire journey. It will cover air, ocean, ground, active (powered) temp-control shipping containers, passive (pre-cooled, no-power required) shipping containers, blankets and more. With capacity being as strained as it is, and delays at ports being as long as they are, you might need different techniques. If you’re responsible for temperature-controlled shipping, this is the session you can’t miss. 

PANELISTS

Doug Wettergren, CEO, DoKaSch Americas
Chris Anderson, EVP, Global Sales, Protek Pharma Worldwide
Michael Haley, Business Development Director, SkyCell Americas
Moderator: Jeff Perata, Director, PBO Logistics, Gilead 

4:15 – 4:30 pm CONNECTING THOSE WHO CARE TO THOSE WHO CURE

Pharma.Aero was established to foster collaboration across industries of Life Science and Medtech shippers and other industry stakeholders. The presentation will highlight how the two giant industries of Life Sciences and Airfreight create supply chains to transport medicine and healing across the planet.

Frank Van Gelder, Secretary General, PHARMA.AERO

4:30 – 4:50 pm  AWARDS CEREMONY

4:45 – 6:00 pm  COCKTAIL RECEPTION

  8:30 am – 4:30 pm TRACK 3: DIGITAL TRANSFORMATION OF HEALTHCARE

Syracuse Room

Chairman:  Randy Bradley, Executive Vice President Digital Transformation in Life Sciences

8:30 – 9:15 am “TRANSFORMATION OF SUPPLY CHAINS THROUGH DIGITALIZATION: A PROCESS FIRST APPROACH”

Life science organizations are challenged to get traction with the digitalization efforts. Recognizing that organizations of varying sizes are at different stages and have different endpoints in mind, it’s prudent to identify where along the digital journeys organizations win and lose. In this highly interactive session, you gain insights into the three key phases of digital transformation and where organizations get stuck.

Speaker: Dr. Randy V. Bradley, Associate Professor of Information Systems and Supply Chain Management, University of Tennessee

9:15 – 9:45 am FACING THE NEW REALITY OF THE COVID PANDEMIC: INFORMATION-DRIVEN AGILITY!

The manufacture of the Pfizer-BioNTech COVID-19 Vaccine and its global delivery proved to be an unprecedented challenge where connectivity between business functions (internal and external), dynamically changing goal posts, monitoring events and outcomes, real time decision making and allocation of scarce resources, have led to New Expectations for problem resolution in the New Reality. The speed of delivery of information got reduced from weeks to minutes. Data analytics became a weapon for the war. Solving historical difficult tasks with rapid response became possible while large scale clinical trials were being conducted along with normal commercial operations. The presentation will provide unique insights into how the organization is being transformed for a New Normal where flexibility of regulatory compliance has been enhanced.

Speaker: TBA

9:45 – 10:15 am  “THE INDUSTRY 4.0 OPERATING PLATFORM TO TRANSFORM THE END-TO-END SUPPLY CHAIN”

The bio-pharmaceutical industry is facing key challenges that are driving supply chain leaders to increase supply chain agility and resilience through digital supply chain transformation. In this session, you learn to vastly improve the way your teams and your supply partner teams work together across pre-clinical, clinical and commercial stages to transform the way every day work activities are accelerated through digitalization . Also, learn how a digital network platform can future-proof your supply chain technology infrastructure with multienterprise applications, such as Supply Chain Work Management, that enables step change improvements in cross-company processes.

John Jacey, Director, Digital Supply Chain Solutions ,TraceLink   

10:15 – 11:00 am  NETWORK BREAK

11:00 – 11:30 am “LEVERAGING SUPPLY CHAIN DATA FOR PROACTIVE DECISION-MAKING BEYOND THE SUPPLY CHAIN”

Internal data sharing is the lifeblood of organizational collaboration. This session will delve into practical ways in which a pharmaceutical company use internal data sharing to promote cross-functional collaboration.

Speaker(s): TBA

11:30 am – 12:00 pm  TECHNOLOGY SHOWCASE 1

12:00 – 12:30 pm   TECHNOLOGY SHOWCASE 2

12:30 – 2:00 pm  NETWORK LUNCHEON

2:00 – 2:45 pm “AVOIDING THE PITFALL OF PRIORITIZING TECHNOLOGY OVER PEOPLE IN YOUR DIGITAL STRATEGY”

Is digital transformation “much ado about nothing”? There are varying goals associated with a digital strategy. Whereas one might be focused on total transformation others might be simply focused on digitizing data and processes. This panel of industry experts will address challenges they have seen or experienced in relation to their digital initiatives and how others can avoid or mitigate the impact of those challenges. Whether you’re in the early stages of your digital journey or farther down the road, there are still vital lessons to learn about how to ensure you prioritize people and the work over tech. Come be part of the conversation.

PANELISTS:

Leon Trevett, Sr. Director, Global Supply Chain, Illumina
Subhrajyoti (Subbu) Panigrahi, Sr. Director, Gilead
David Volk, Executive Director, Clinical Supply Chain Planning, Genentech
Heather Erickson, Vice President, Supply Chain Management & Business Operations, Sangamo
Aparna Seksaria, Product Manager, SAP Life Science Project Management, SAP
Moderator: Linda Bowers, Global Head Life Sciences Industry Solutions, Servicenow

3:15 – 4:00 pm NETWORK BREAK 

4:00 – 4:30 pm  OVERCOMING THE INADEQUACY OF TRADITIONAL BUSINESS CONTINUITY STRATEGIES IN THE POST PANDEMIC WORLD

Besides representing extraordinary health and social emergency, the pandemic has proved to be a major threat to companies and the continuity of their business processes. The presentation will demonstrate how the traditional strategic capability of an organization of business continuity must be made more robust with an extended end-to-end supply chain to minimize the loss of human life. Fundamental issues will be addressed to safeguard an enterprise in terms of volatility in supply and demand, disconnected systems, diversification of supply, lead times on the supply and demand side, disruptions in the transportation network, level and placement of inventory, visibility of adverse conditions and outcomes, eCommerce capability and overall maturity of the digital supply chain.

Speaker: TBD

WRAP UP

4:30 – 4:50 pm  AWARDS CEREMONY

4:45 – 6:00 pm  COCKTAIL RECEPTION

BSMA Summit Parade of Sponsors

MEDIA

PLATINUM

GOLD

SILVER

BRONZE

EXHIBITOR

LANYARD

Pin It on Pinterest

Share This